Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability

Thrombolysis has been a standard treatment for ischemic stroke. However, only 2-7% patients benefit from it because the thrombolytic agent has to be injected within 4.5 h after the onset of symptoms to avoid the increasing risk of intracerebral hemorrhage. As the only clinically approved neuroprotec...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Qu, Cai, Yu, Li, Sihan, Liu, Haoran, Zhou, Xingyu, Lu, Chunqiang, Gao, Xihui, Qian, Jun, Zhang, Jun, Ju, Shenghong, Li, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381251/
https://www.ncbi.nlm.nih.gov/pubmed/28382161
http://dx.doi.org/10.7150/thno.18219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381251/
https://www.ncbi.nlm.nih.gov/pubmed/28382161
http://dx.doi.org/10.7150/thno.18219

Ejemplares similares